A Report of Rabbit Syndrome Who Benefited from Sigma 1 Agonist Fluvoxamine
Clinical Psychopharmacology and Neuroscience
;
: 134-138, 2019.
Artigo
em Inglês
| WPRIM
| ID: wpr-739462
ABSTRACT
Rabbit Syndrome is an uncommon side effect of antipsychotic treatment. Although it is usually associated with typical antipsychotics, it can also be related to atypical antipsychotics. Anticholinergics are the most accepted treatment approach in treating Rabbit Syndrome. Fluvoxamine is a member of selective serotonin reuptake inhibitors and it is a potent agonist of sigma 1 receptors. In this article, we report a Rabbit Syndrome case who has benefited from fluvoxamine, in terms of both depressive disorder and Rabbit Syndrome; and present the data on the effects of sigma 1 agonist fluvoxamine on numerous movement disorders.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Antipsicóticos
/
Fluvoxamina
/
Inibidores Seletivos de Recaptação de Serotonina
/
Receptores sigma
/
Antagonistas Colinérgicos
/
Transtorno Depressivo
/
Transtornos dos Movimentos
Idioma:
Inglês
Revista:
Clinical Psychopharmacology and Neuroscience
Ano de publicação:
2019
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS